Table 1 Main clinical and laboratory features of 29 patients with systemic sclerosis (SSc)
From: Absolute count of T and B lymphocyte subsets is decreased in systemic sclerosis
Gender (male/female) | 1/28 |
Age (mean ± SD) | 56.3 ± 12.9 |
SSc type (limited/diffuse) | 22/7 |
Duration of disease (median, months) | 42 (1 - 390) |
Raynaud phenomenon (no/yes) | 0/29 |
MRSS (median) | 7 (2 - 24) |
Renal involvement (no/yes) | 26/3 |
Lung involvement (no/yes) | 21/8 |
Oesophagus involvement (no/yes) | 20/9 |
Antinuclear antibodies on HEp-2 cell line (negative/anti-centromere/anti-topoisomerase I) | 7/16/6 |